Application 075189
- Type
- ANDA
- Sponsor
- IMPAX LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NABUMETONE | NABUMETONE | TABLET;ORAL | 500MG | No | No |
| 002 | NABUMETONE | NABUMETONE | TABLET;ORAL | 750MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075189-001 | NABUMETONE | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | ||
| A075189-002 | NABUMETONE | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | 2000-05-26 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | 2001-09-24 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A075189-001 | NABUMETONE | 500MG | TABLET / ORAL | AB | 2000-05-26 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A075189-002 | NABUMETONE | 750MG | TABLET / ORAL | AB | RS | 2001-09-24 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A075189-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A075189-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A075189-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A075189-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A075189-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A075189-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A075189-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A075189-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nabumetone | NABUMETONE | Westminster Pharmaceuticals, LLC | 264df44a-e294-4d9b-9113-92859cb08c20 | 2024-08-30 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Bryant Ranch Prepack | 62f2e0bf-e5c8-480c-ac5e-401ced3bbc67 | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| RELAFEN DS | NABUMETONE | Carwin Pharmaceutical Associates, LLC | a9a0af85-6c43-4a2d-ba75-0be4ca64c931 | 2024-01-08 | Boxed warning, Warnings, Adverse reactions | NABUMETONE |
| Nabumetone | NABUMETONE | Lupin Pharmaceuticals, Inc. | cf96d189-5417-4181-a5fb-169b269560a2 | 2023-11-03 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Chartwell RX, LLC | 84bb2887-bab4-46ae-a07c-fa2a32c04b50 | 2023-01-20 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Proficient Rx LP | 0870c3c9-bfce-4722-8779-8775644196d3 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Proficient Rx LP | 7a1643bf-6627-4b12-8246-6acc40517cf2 | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Proficient Rx LP | f4392863-ed3f-4fbd-8260-49827609aa2e | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Asclemed USA, Inc. | 04a71deb-2c9d-436c-a574-e5991b6a5248 | 2022-03-07 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
| Nabumetone | NABUMETONE | Proficient Rx LP | 079a8a9e-6d71-414a-83f3-ef68e323c1fd | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | Nabumetone NABUMETONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0115-1657 | Nabumetone | Nabumetone | Impax Generics | ANDA | Current |
| 0115-1657 | Nabumetone | Nabumetone | Impax Generics | ANDA | Current |
| 0115-1657 | Nabumetone | Nabumetone | Amneal Pharmaceuticals of New York LLC | ANDA | Current |
| 0115-1658 | Nabumetone | Nabumetone | Impax Generics | ANDA | Current |
| 0115-1658 | Nabumetone | Nabumetone | Impax Generics | ANDA | Current |
| 0115-1658 | Nabumetone | Nabumetone | Amneal Pharmaceuticals of New York LLC | ANDA | Current |
| 0615-7666 | Nabumetone | Nabumetone | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 0615-7667 | Nabumetone | Nabumetone | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 43063-859 | Nabumetone | Nabumetone | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-859 | Nabumetone | Nabumetone | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-859 | Nabumetone | Nabumetone | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-859 | Nabumetone | Nabumetone | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-859 | Nabumetone | Nabumetone | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 45865-997 | Nabumetone | Nabumetone | medsource pharmaceuticals | ANDA | Current |
| 55700-752 | Nabumetone | Nabumetone | Quality Care Products, LLC | ANDA | Current |
| 55700-765 | Nabumetone | Nabumetone | Quality Care Products, LLC | ANDA | Current |
| 55700-765 | Nabumetone | Nabumetone | Quality Care Products, LLC | ANDA | Current |
| 61919-159 | NABUMETONE | NABUMETONE | Direct Rx | ANDA | Current |
| 61919-159 | NABUMETONE | NABUMETONE | DIRECT RX | ANDA | Current |
| 61919-159 | NABUMETONE | NABUMETONE | DIRECT RX | ANDA | Current |
| 61919-160 | NABUMETONE | NABUMETONE | Direct Rx | ANDA | Current |
| 68788-7532 | Nabumetone | Nabumetone | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-7532 | Nabumetone | Nabumetone | Preferred Pharmaceuticals, Inc. | ANDA | Current |